Literature DB >> 3739594

Cardiac arrhythmias in familial amyloid polyneuropathy during anaesthesia.

P Eriksson, K Boman, B Jacobsson, B O Olofsson.   

Abstract

There is an increased risk of anaesthetic complications in patients with myocardial disorders. The present paper concerns seven patients with familial amyloid polyneuropathy, who developed severe bradycardia or heart block during anaesthesia. Amyloid infiltration of the cardiac conducting tissues probably increases their susceptibility to anaesthetic agents. Dysfunction of autonomic nerves may also diminish cardiac impulse formation and conduction. In addition, the possibility of contributing succinylcholine-induced hyperkalaemia cannot be excluded. There was a prompt response to infusion of isoproterenol in all patients so treated, but the insertion of a temporary pacemaker prior to anaesthesia should, nevertheless, be seriously considered in this group of patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3739594     DOI: 10.1111/j.1399-6576.1986.tb02422.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  4 in total

1.  Anesthetic management for a patient with amyloidosis.

Authors:  Y Hirabayashi; S Yokosuka; K Miyashita; R Shimizu
Journal:  J Anesth       Date:  1992-04       Impact factor: 2.078

2.  A guide to improving the care of patients with fragility fractures.

Authors:  Susan V Bukata; Benedict F Digiovanni; Susan M Friedman; Harry Hoyen; Amy Kates; Stephen L Kates; Simon C Mears; Daniel A Mendelson; Fernando H Serna; Frederick E Sieber; Wakenda K Tyler
Journal:  Geriatr Orthop Surg Rehabil       Date:  2011-01

Review 3.  Preventing postoperative complications in the elderly.

Authors:  Frederick E Sieber; Sheila Ryan Barnett
Journal:  Anesthesiol Clin       Date:  2011-01-05

4.  Anaesthetic management of a patient with familial amyloid polyneuropathy of the Portuguese type.

Authors:  J Castro Tavares; L Maciel
Journal:  Can J Anaesth       Date:  1989-03       Impact factor: 5.063

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.